SCHEMBL11979769

SCHEMBL11979769

CCc1cnc(-c2ccc(F)cc2F)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
RXRA P19793 3/20 0.37
GRIN1 Q05586 3/20 0.37
GRIN2B Q13224 3/20 0.37
DPP4 P27487 1/20 0.37
NCOA1 Q15788 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
KMO O15229 2/20 0.36
ALPL P05186 1/20 0.35
KIT P10721 1/20 0.34
PIM1 P11309 1/20 0.34
FLT3 P36888 1/20 0.34
CDK7 P50613 1/20 0.34
KCNH2 Q12809 1/20 0.34
PIM3 Q86V86 1/20 0.34
HASPIN Q8TF76 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11979772 0.83 GCGR (0.45) GAASMN1; SMN2L3MBTL1GCGR
SCHEMBL11979778 0.82 RARB (0.47) GAASMN1; SMN2L3MBTL1GCGR
SCHEMBL11979779 0.82 RARB (0.47) GAASMN1; SMN2L3MBTL1GCGR
SCHEMBL11979777 0.82 RARB (0.47) GAASMN1; SMN2L3MBTL1GCGR
SCHEMBL11985001 0.80 CASP6 (0.44) RXRAGRIN1GRIN2BDPP4KMO
SCHEMBL15060602 0.80 GRM2 (0.47) GAASMN1; SMN2L3MBTL1KMOALPL
SCHEMBL12716146 0.79 TUBB4A (0.47) LMNA
SCHEMBL17356626 0.77 USP7 (0.39) GAASMN1; SMN2PIM1FLT3LMNA
SCHEMBL31627696 0.76 ALDH1A1 (0.41) DPP4L3MBTL1KMOALPLMAOB
SCHEMBL27964264 0.76 ALOX5AP (0.45) GAARXRAGRIN1GRIN2BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993754-B2 Iridium complex and light emitting material formed from same NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2015-03-31 US disclosed
US-8993754-B2 Iridium complex and light emitting material formed from same NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2015-03-31 US disclosed
US-20120208999-A1 IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2012-08-16 US disclosed
US-20120208999-A1 IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208999-A1 IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME LUC7L2, CRY1, INTS9 GAA 3091/4885RXRA 3000/4885GRIN1 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.